Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $523.5600 (1.74%) ($513.0000 - $530.6600) on Mon. Oct. 19, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.85% (three month average) | | RSI | 74 | | Latest Price | $523.5600(1.74%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | | Weekly Trend | REGN advances 4.8% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(65%) XLV(52%) XBI(49%) QQQ(42%) IWF(41%) | | Factors Impacting REGN price | REGN will decline at least -1.425% in a week (0% probabilities).
VIXM(-14%) TLT(-9%) UUP(-6%) SHY(-4%) TIP(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.425% (StdDev 2.85%) | | Hourly BBV | 0 () | | Intraday Trend | 1.5% | | | | | |
|
| 5 Day Moving Average | $514.96(1.67%) | | 10 Day Moving Average | $505.24(3.63%) | | 20 Day Moving Average | $496.26(5.5%) | | To recent high | -11.6% | | To recent low | 15.9% | | Market Cap | $55.512b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |